ANALYSIS OF APPROACHES OF INDIVIDUAL ASIAN COUNTRIES TO ASSESS BIOLOGICAL RISKS

Оver the past decade, the increase in outbreaks of infectious diseases such as COVID-19, monkeypox, etc. has forced us to reconsider the approach to assessing biological risks in ensuring biological safety. The rapid global spread of these diseases is putting enormous pressure on governments and international agencies to diagnose, treat and control outbreaks. In this regard, it is necessary to study their potential in the field of biosecurity, including the diagnosis, treatment, and research of infectious diseases and improve the rules and guidelines for biodefense. An analysis of foreign experience, including China, Pakistan, Kyrgyzstan, Tajikistan and Kazakhstan was carried out on biological risk assessment, which requires constant monitoring and assessment of emerging threats and evolving risks. Monitoring includes conducting regular infectious disease surveillance, analyzing trends and patterns of disease transmission, and evaluating the effectiveness of prevention and control measures. Countries can adapt their approaches and strategies to address new and emerging threats by continuously monitoring and reassessing biological risks. In conclusion, the experience of foreign countries in biological risk assessment provides valuable information on best practices, strategies and technologies that can help improve global biological risk management and mitigation efforts. This review article highlights the importance of reliable surveillance systems, effective communication and cooperation, investment in research and development, constant vigilance and preparedness for biological threats.

1. Centres for Disease Control and Prevention. Guidelines for Safe Work Practices in Human and Animal Medical Diagnostic Laboratories. https://www.cdc.gov/mmwr/preview/mmwrhtml/su6101a1.htm

2. Laboratory Biosafety and Biosecurity Risk Assessment Technical Guidance Document. https://internationalbiosafety.org/wp-content/uploads/2019/08/Laboratory-Biosafety-and-Biosecurity-Risk-Assessment

3. Prakticheskoe rukovodstvo po biologicheskoĭ bezopasnosti v laboratorny`kh usloviyakh v svyazi s koronavirusnoĭ infekczieĭ (COVID-19). https://apps.who.int/iris/bitstream/handle/10665/339056/WHO

4. Pravila perevozki opasny`kh gruzov. https://www.iata.org/contentassets/6fea26dd84d24b26a7a1fd

5. Konvencziya o biologicheskom oruzhii. https://ru.wikipedia.org/wiki/Konvencziya_o_

6. Direktiva Evropeĭskogo parlamenta i Soveta Evropeĭskogo Soyuza 2012/18/ES ot 4 iyulya 2012 g. o kontrole krupny`kh avariĭ, svyazanny`kh s opasny`mi veshhestvami, izmenyayushhaya i vposledstvii otmenyayushhaya Direktivu 96/82/EC Soveta ES. https://wecoop.eu/wp-content/uploads/2020/04/

7. Biobezopasnost` v mikrobiologicheskikh i biomediczinskikh laboratoriyakh. – Czentry` SShA po kontrolyu i profilaktike zabolevanij (BMBL). https://www.cdc.gov/labs/pdf/CDC-Biosafety

8. Canadian Biosafety Standard, Third Edition // Public Health Agency of Canada. – 2022. – P. 45-53. – ISBN: 978-0-660-45739-0

9. Risk management - Principles and guidelines. – Standards New Zealand. https://www.standards.govt.nz/shop/

10. Dillon M., Lobo-Gerrero L. Biopolitika bezopasnosti v 21 veke: Vvedenie. // Obzor mezhdunarodny`kh issledovanij. – 2008. – No.1. – P. 265-92.

11. O biologicheskoj bezopasnosti Respubliki Kazakhstan. – Zakon respubliki Kazakhstan. https://online.zakon.kz/Document/?doc_id=39944002

12. Ob utverzhdenii metodiki upravleniya biologicheskimi riskami. – Әdi`let. – URL: https://adilet.zan.kz/rus/docs/V2200030058

13. Ob utverzhdenii Metodiki upravleniya biologicheskimi riskami. – Әdi`let. – URL: https://adilet.zan.kz/rus/docs/V2200030428

14. Ob utverzhdenii Metodiki upravleniya biologicheskimi riskami. – Әdi`let. – URL: https://adilet.zan.kz/rus/docs/V2200030157

15. Ob utverzhdenii Metodiki upravleniya biologicheskimi riskami. – Әdi`let. – URL: https://adilet.zan.kz/rus/docs/V2300031867

16. Kartakhenskij protokol po biobezopasnosti k Konvenczii po biologicheskomu raznoobraziyu. – URL: https://www.un.org/ru/documents/decl_conv/conventions/pdf/cartagena.pdf

17. Xiaoyue Y., Joseph T. China's Experience in Responding to the COVID-19 Outbreak // The Lancet Infectious Diseases. – 2020. – Vol. 20 (7).

18. Ning Zh. et al. Risk assessment and management of infectious diseases in China: Challenges and opportunities // Biosafety and Health. – 2020. – Vol. 2 (2).

19. Zhang W., Du G., Li J. et al. Biological risk assessment in China: A review of regulations, research, and perspectives // Biosafety and Health. – 2021. – Vol. 3(1). – P. 26-32. doi: 10.1016/j.bsheal.2020.12.004.

20. Wang C., Dong Y., Li M., Li X. Research progress of qualitative and quantitative risk assessment of genetically modified organisms // Biotechnology Bulletin. – 2020. – Vol. 36(12). – P. 155-162.

21. National Institute of Health. Islamic Republic of Pakistan. – URL: https://www.nih.org.pk/home

22. Government of Pakistan. Pakistan Environmental Protection Agency. – URL: https://environment.gov.pk/SiteImage/Misc/files/Guidelines/BiosftyGlines2005.pdf

23. Pakistan Biological Safety Association. International Federation of Biosafety Associations. – URL: https://internationalbiosafety.org/ifba_members/pakistan-biological-safety-association/

24. Khalil A., Tanvir F., Shinvari Z.K. Biologicheskaya gotovnost` Pakistana v otnoshenii biozashhity`, strategij biologicheskoj zashhity` i politicheskikh mer // Zhurnal bioterrorizma i biologicheskoj zashhity`. – 2015. – № 6. – С. 2.

25. Abid K., Bari Ya., Yunas M., Dzhavaid S.T., Imran A. Progress e`pidemii COVID 19 v Pakistane // Aziatsko-Tikhookeanskij zhurnal obshhestvennogo zdravookhraneniya. – 2020.

26. Kastrision E.V., Vidzhayan V. Kartirovanie riskov biobezopasnosti i analiz probelov v Yugo-Vostochnoj Azii // Zhurnal po biobezopasnosti i biozashhishhennosti. – 2020.

27. COVID W. Global`ny`j forum po issledovaniyam i innovacziyam PHEIC: na puti k dorozhnoj karte issledovanij.

28. Gavrilova O.N., Gajbulin D.Sh., Samsonova T.G. Obespechenie biologicheskoj bezopasnosti v Ky`rgy`zskoj Respublike // Mediczina Ky`rgy`stana. – 2011.

29. Mozgova G.V., Kil`chevskogo A.V., Shejko R.I. Chetverty`j Naczional`ny`j doklad po vy`polneniyu Respublikoj Belarus` obyazatel`stv po Kartakhenskomu protokolu biobezopasnosti. – 2021.

30. Nurgaziev R. Kak obespechit` biobezopasnost` strany` // Mneniya. – 2020.

31. Ukaz Prezidenta Ky`rgy`zskoj Respubliki ot 20 dekabrya 2021 goda № 57. Konczepcziya naczional`noj bezopasnosti Ky`rgy`zskoj Respubliki. https://online.zakon.kz/document/?doc_id=329649

32. Nurgaziev R.Z., Koshemetov Zh.K., Krutckaya E.D., Bogdanova M.I., Sugirbaeva G.D. Osobo opasny`e infekczionny`e zabolevaniya sredi zhivotny`kh na territorii Respubliki Tadzhikistan // Vestnik AGAU. – 2016. – № 3. – С. 137.

33. Nazarova O.D., Makhmudov K.B., Muminov A.A., Dzhumaev Sh.N. Oczenka riskov biologicheskoj bezopasnosti v Tadzhikistane // Institut problem biologicheskoj bezopasnosti TASKhN. – 2019.

34. Zakon Respubliki Tadzhikistan ot 29 yanvarya 2021 goda #1759. Ob obespechenii biologicheskoj bezopasnosti i biologicheskoj zashhity`. https://online.zakon.kz/Document/?doc_id=34813455